Inflammatory and oxidative stress responses to high-carbohydrate and high-fat meals in healthy humans

Journal of Nutrition and Metabolism

Volumn 2012, Issue , 2012, Pages

  Gregersen, S ^a,b   Samocha Bonet, D ^b   Heilbronn, L K ^b,c   Campbell, L V ^b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84870473237     PISSN: 20900724     EISSN: 20900732     Source Type: Journal    
DOI: 10.1155/2012/238056     Document Type: Article

References (44)

1. Evans J. L., Goldfine I. D., Maddux B. A., Grodsky G. M., Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Reviews 2002 23 5 599 622 2-s2.0-0036796875 10.1210/er.2001-0039 (Pubitemid 35191625)
2. Wellen K. E., Hotamisligil G. S., Inflammation, stress, and diabetes. Journal of Clinical Investigation 2005 115 5 1111 1119 2-s2.0-18244370762 10.1172/JCI200525102 (Pubitemid 40629025)
3. Stocker R., Keaney J. F. Jr., Role of oxidative modifications in atherosclerosis. Physiological Reviews 2004 84 4 1381 1478 2-s2.0-4644310560 10.1152/physrev.00047.2003 (Pubitemid 39302636)
4. Bloch-Damti A., Bashan N., Proposed mechanisms for the induction of insulin resistance by oxidative stress. Antioxidants and Redox Signaling 2005 7 11-12 1553 1567 2-s2.0-28844461131 10.1089/ars.2005.7.1553 (Pubitemid 41767991)
5. Festa A., Hanley A. J. G., Tracy R. P., D'Agostino R. Jr., Haffner S. M., Inflammation in the prediabetic state is related to increased insulin resistance rather than decreased insulin secretion. Circulation 2003 108 15 1822 1830 2-s2.0-0142053961 10.1161/01.CIR.0000091339.70120.53 (Pubitemid 37296091)
6. Hotamisligil G. S., Shargill N. S., Spiegelman B. M., Adipose expression of tumor necrosis factor- : direct role in obesity-linked insulin resistance. Science 1993 259 5091 87 91 2-s2.0-0027459878 (Pubitemid 23036092)
7. Keaney J. F. Jr., Larson M. G., Vasan R. S., Wilson P. W. F., Lipinska I., Corey D., Massaro J. M., Sutherland P., Vita J. A., Benjamin E. J., Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham study. Arteriosclerosis, Thrombosis, and Vascular Biology 2003 23 3 434 439 2-s2.0-0037342568 10.1161/01.ATV.0000058402.34138.11 (Pubitemid 36337219)
8. Hoehn K. L., Salmon A. B., Hohnen-Behrens C., Turner N., Hoy A. J., Maghzal G. J., Stocker R., Van Remmen H., Kraegen E. W., Cooney G. J., Richardson A. R., James D. E., Insulin resistance is a cellular antioxidant defense mechanism. Proceedings of the National Academy of Sciences of the United States of America 2009 106 42 17787 17792 2-s2.0-70449552861 10.1073/pnas.0902380106
9. Houstis N., Rosen E. D., Lander E. S., Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006 440 7086 944 948 2-s2.0-33645860825 10.1038/nature04634
10. Hotamisligil G. S., Inflammation and metabolic disorders. Nature 2006 444 7121 860 867 2-s2.0-33845866857 10.1038/nature05485 (Pubitemid 46024993)
11. Carroll M. F., Schade D. S., Timing of antioxidant vitamin ingestion alters postprandial proatherogenic serum markers. Circulation 2003 108 1 24 31 2-s2.0-0038164595 10.1161/01.CIR.0000074221.68903.77 (Pubitemid 36859015)
12. Manning P. J., Sutherland W. H. F., McGrath M. M., De Jong S. A., Walker R. J., Williams M. J. A., Postprandial cytokine concentrations and meal composition in obese and lean women. Obesity 2008 16 9 2046 2052 2-s2.0-50649125777 10.1038/oby.2008.334
13. Peake P. W., Kriketos A. D., Campbell L. V., Charlesworth J. A., Response of the alternative complement pathway to an oral fat load in first-degree relatives of subjects with type II diabetes. International Journal of Obesity 2005 29 4 429 435 2-s2.0-16244365517 10.1038/sj.ijo.0802644 (Pubitemid 40462767)
14. Poppitt S. D., Keogh G. F., Lithander F. E., Wang Y., Mulvey T. B., Chan Y. K., McArdle B. H., Cooper G. J. S., Postprandial response of adiponectin, interleukin-6, tumor necrosis factor- and C-reactive protein to a high-fat dietary load. Nutrition 2008 24 4 322 329 2-s2.0-39949084669 10.1016/j.nut.2007.12.012
15. Lim S., Won H., Kim Y., Antioxidant enzymes induced by repeated intake of excess energy in the form of high-fat, high-carbohydrate meals are not sufficient to block oxidative stress in healthy lean individuals. British Journal of Nutrition 2011 106 10 1544 1551
16. Ceriello A., Bortolotti N., Motz E., Pieri C., Marra M., Tonutti L., Lizzio S., Feletto F., Catone B., Taboga C., Meal-induced oxidative stress and low-density lipoprotein oxidation in diabetes: the possible role of hyperglycemia. Metabolism 1999 48 12 1503 1508 2-s2.0-13044287359
17. Viardot A., Heilbronn L. K., Herzog H., Gregersen S., Campbell L. V., Abnormal postprandial PYY response in insulin sensitive nondiabetic subjects with a strong family history of type 2 diabetes. International Journal of Obesity 2008 32 6 943 948 2-s2.0-47249164333 10.1038/ijo.2008.24 (Pubitemid 351986224)
18. Heilbronn L. K., Gregersen S., Shirkhedkar D., Hu D., Campbell L. V., Impaired fat oxidation after a single high-fat meal in insulin-sensitive nondiabetic individuals with a family history of type 2 diabetes. Diabetes 2007 56 8 2046 2053 2-s2.0-34547555525 10.2337/db06-1687 (Pubitemid 47195816)
19. Erridge C., Attina T., Spickett C. M., Webb D. J., A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. American Journal of Clinical Nutrition 2007 86 5 1286 1292 2-s2.0-36249005027 (Pubitemid 350126229)
20. Smith C. W., cwsmith@bcm.tmc.edu Diet and leukocytes. American Journal of Clinical Nutrition 2007 86 5 1257 1258 (Pubitemid 350126224)
21. Patel C., Ghanim H., Ravishankar S., Chang L. S., Viswanathan P., Mohanty P., Dandona P., Prolonged reactive oxygen species generation and nuclear factor- B activation after a high-fat, high-carbohydrate meal in the obese. Journal of Clinical Endocrinology and Metabolism 2007 92 11 4476 4479 2-s2.0-35948940807 10.1210/jc.2007-0778 (Pubitemid 350074773)
22. Heilbronn L. K., Campbell L. V., Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Current Pharmaceutical Design 2008 14 12 1225 1230 2-s2.0-47149096915 10.2174/138161208784246153 (Pubitemid 351997835)
23. Febbraio M. A., Hiscock N., Saccheti M., Fischer C. P., Pedersen B. K., Interleukin-6 is a novel factor mediating glucose homeostasis during skeletal muscle contraction. Diabetes 2004 53 7 1643 1648 2-s2.0-3042721664 10.2337/diabetes.53.7.1643 (Pubitemid 38864744)
24. Petersen A. M., Pedersen B. K., bkp@rh.dk The role of IL-6 in mediating the anti-inflammatory effects of exercise. Journal of Physiology and Pharmacology 2006 57 supplement 10 43 51 (Pubitemid 46548766)
25. Krook A., IL-6 and metabolism-new evidence and new questions. Diabetologia 2008 51 7 1097 1099 2-s2.0-44749090165 10.1007/s00125-008-1019-7
26. Carey A. L., Steinberg G. R., Macaulay S. L., Thomas W. G., Holmes A. G., Ramm G., Prelovsek O., Hohnen-Behrens C., Watt M. J., James D. E., Kemp B. E., Pedersen B. K., Febbraio M. A., Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 2006 55 10 2688 2697 2-s2.0-33750859187 10.2337/db05-1404 (Pubitemid 44923666)
27. Holmes A. G., Mesa J. L., Neill B. A., Chung J., Carey A. L., Steinberg G. R., Kemp B. E., Southgate R. J., Lancaster G. I., Bruce C. R., Watt M. J., Febbraio M. A., Prolonged interleukin-6 administration enhances glucose tolerance and increases skeletal muscle PPAR and UCP2 expression in rats. Journal of Endocrinology 2008 198 2 367 374 2-s2.0-51349111709 10.1677/JOE-08-0113
28. Matthews V. B., Allen T. L., Risis S., Chan M. H. S., Henstridge D. C., Watson N., Zaffino L. A., Babb J. R., Boon J., Meikle P. J., Jowett J. B., Watt M. J., Jansson J. O., Bruce C. R., Febbraio M. A., Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia 2010 53 11 2431 2441 2-s2.0-77957661299 10.1007/s00125-010-1865-y
29. Dixon N. C., Hurst T. L., Talbot D. C. S., Tyrrell R. M., Thompson D., Active middle-aged men have lower fasting inflammatory markers but the postprandial inflammatory response is minimal and unaffected by physical activity status. Journal of Applied Physiology 2009 107 1 63 68 2-s2.0-67650084402 10.1152/japplphysiol.91532.2008
30. Thompson S. R., McCaskie P. A., Beilby J. P., Hung J., Jennens M., Chapman C., Thompson P., Humphries S. E., IL18 haplotypes are associated with serum IL-18 concentrations in a population-based study and a cohort of individuals with premature coronary heart disease. Clinical Chemistry 2007 53 12 2078 2085 2-s2.0-36649017894 10.1373/clinchem.2007.092692 (Pubitemid 350197290)
31. Zilverschoon G. R. C., Tack C. J., Joosten L. A. B., Kullberg B. J., van der Meer J. W. M., Netea M. G., Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus. International Journal of Obesity 2008 32 9 1407 1414 2-s2.0-51849099326 10.1038/ijo.2008.109
32. Fischer C. P., Perstrup L. B., Berntsen A., Eskildsen P., Pedersen B. K., Elevated plasma interleukin-18 is a marker of insulin-resistance in type 2 diabetic and non-diabetic humans. Clinical Immunology 2005 117 2 152 160 2-s2.0-26044457651 10.1016/j.clim.2005.07.008 (Pubitemid 41407725)
33. Hung J., McQuillan B. M., Chapman C. M. L., Thompson P. L., Beilby J. P., Elevated interleukin-18 levels are associated with the metabolic syndrome independent of obesity and insulin resistance. Arteriosclerosis, Thrombosis, and Vascular Biology 2005 25 6 1268 1273 2-s2.0-20144370398 10.1161/01.ATV. 0000163843.70369.12 (Pubitemid 40776620)
34. Netea M. G., Joosten L. A. B., Lewis E., Jensen D. R., Voshol P. J., Kullberg B. J., Tack C. J., Van Krieken H., Kim S. H., Stalenhoef A. F., Van De Loo F. A., Verschueren I., Pulawa L., Akira S., Eckel R. H., Dinarello C. A., Van Den Berg W., Van Der Meer J. W. M., Deficiency of interleukin-18 in mice leads to hyperphagia, obesity and insulin resistance. Nature Medicine 2006 12 6 650 656 2-s2.0-33745009509 10.1038/nm1415 (Pubitemid 43865233)
35. Bruun J. M., Stallknecht B., Helge J. W., Richelsen B., Interleukin-18 in plasma and adipose tissue: effects of obesity, insulin resistance, and weight loss. European Journal of Endocrinology 2007 157 4 465 471 2-s2.0-35548978622 10.1530/EJE-07-0206 (Pubitemid 350018450)
36. Esposito K., Nappo F., Giugliano F., Di Palo C., Ciotola M., Barbieri M., Paolisso G., Giugliano D., Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. American Journal of Clinical Nutrition 2003 78 6 1135 1140 2-s2.0-0642307072 (Pubitemid 39663454)
37. Rosenson R. S., Wolff D. A., Huskin A. L., Helenowski I. B., Rademaker A. W., Fenofibrate therapy ameliorates fasting and postprandial lipoproteinemia, oxidative stress, and the inflammatory response in subjects with hypertriglyceridemia and the metabolic syndrome. Diabetes Care 2007 30 8 1945 1951 2-s2.0-34547687824 10.2337/dc07-0015 (Pubitemid 47219398)
38. Saxena R., Madhu S. V., Shukla R., Prabhu K. M., Gambhir J. K., Postprandial hypertriglyceridemia and oxidative stress in patients of type 2 diabetes mellitus with macrovascular complications. Clinica Chimica Acta 2005 359 1-2 101 108 2-s2.0-23644461391 10.1016/j.cccn.2005.03.036 (Pubitemid 41116301)
39. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. Journal of Clinical Investigation 2009 119 3 573 581 2-s2.0-67650815430 10.1172/JCI37048
40. Abdul-Ghani M. A., Jani R., Chavez A., Molina-Carrion M., Tripathy D., DeFronzo R. A., Mitochondrial reactive oxygen species generation in obese non-diabetic and type 2 diabetic participants. Diabetologia 2009 52 4 574 582 2-s2.0-61449147889 10.1007/s00125-009-1264-4
41. Bao W., Song F., Li X., Rong S., Yang W., Zhang M., Yao P., Hao L., Yang N., Hu F. B., Liu L., Plasma heme oxygenase-1 concentration is elevated in individuals with type 2 diabetes mellitus. PLoS One 2010 5 8 2-s2.0-77957882550 10.1371/journal.pone.0012371 e12371
42. Avogaro A., Pagnin E., Calò L., Monocyte NADPH oxidase subunit p22phox and inducible hemeoxygenase-1 gene expressions are increased in type II diabetic patients: relationship with oxidative stress. Journal of Clinical Endocrinology and Metabolism 2003 88 4 1753 1759 2-s2.0-0037683670 10.1210/jc.2002-021025 (Pubitemid 36623400)
43. Bruce C. R., Carey A. L., Hawley J. A., Febbraio M. A., Intramuscular heat shock protein 72 and heme oxygenase-1 mRNA are reduced in patients with type 2 diabetes: evidence that insulin resistance is associated with a disturbed antioxidant defense mechanism. Diabetes 2003 52 9 2338 2345 2-s2.0-0042822096 10.2337/diabetes.52.9.2338 (Pubitemid 37059505)
44. Ndisang J. F., Jadhav A., Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats. Endocrinology 2009 150 6 2627 2636 2-s2.0-66649132533 10.1210/en.2008-1370